Cargando...
Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy
In the last two decades, monoclonal antibodies have revolutionized the therapy of cancer patients. Although antibody therapy has continuously been improved, still a significant number of patients do not benefit from antibody therapy. Therefore, rational optimization of the antibody molecule by Fc en...
Guardado en:
| Publicado en: | Transfus Med Hemother |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
S. Karger GmbH
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5649276/ https://ncbi.nlm.nih.gov/pubmed/29070978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000479980 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|